ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Werewolf Therapeutics Inc

Werewolf Therapeutics Inc (HOWL)

3.01
-0.24
(-7.38%)
Closed June 15 4:00PM
3.05
0.04
(1.33%)
After Hours: 7:59PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
3.01
Bid
3.05
Ask
3.37
Volume
193,562
3.01 Day's Range 3.27
1.5735 52 Week Range 8.1939
Market Cap
Previous Close
3.25
Open
3.27
Last Trade
35
@
3.05
Last Trade Time
Financial Volume
$ 603,882
VWAP
3.1198
Average Volume (3m)
187,057
Shares Outstanding
42,737,191
Dividend Yield
-
PE Ratio
-3.48
Earnings Per Share (EPS)
-0.87
Revenue
19.94M
Net Profit
-37.37M

About Werewolf Therapeutics Inc

Werewolf Therapeutics Inc is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. Werewolf Therapeutics Inc is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Werewolf Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker HOWL. The last closing price for Werewolf Therapeutics was $3.25. Over the last year, Werewolf Therapeutics shares have traded in a share price range of $ 1.5735 to $ 8.1939.

Werewolf Therapeutics currently has 42,737,191 shares outstanding. The market capitalization of Werewolf Therapeutics is $129.92 million. Werewolf Therapeutics has a price to earnings ratio (PE ratio) of -3.48.

HOWL Latest News

Werewolf Therapeutics to Present Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors

-  WTX-124 was shown to be clinically active and generally well-tolerated in patients who were relapsed/refractory to immune checkpoint inhibitor therapy - -  Encouraging single agent clinical...

Werewolf Therapeutics to Participate at the Jefferies Global Healthcare Conference

WATERTOWN, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of...

Werewolf Therapeutics to Present Updated Data from Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors at 2024 ASCO Annual Meeting

- Updated single agent dose escalation data continues to demonstrate that WTX-124 is well tolerated and clinically active in patients with checkpoint inhibitor therapy relapsed/refractory cancers...

Werewolf Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

— Company to present an update of its ongoing monotherapy and combination Phase 1/1b trial of WTX-124 in advanced or metastatic solid tumors at ASCO — — Company plans to present interim...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.48-13.75358166193.493.6952.952639283.22454638CS
4-1.86-38.19301848054.875.732.952188584.07278196CS
12-2.81-48.28178694165.826.892.951870575.06594829CS
260.155.244755244762.868.19392.75132198225.26213258CS
52-0.6-16.6204986153.618.19391.57353466393.71784549CS
156-9.47-75.881410256412.4821.671.392143004.71778917CS
260-15.2-83.470620538218.2123.991.392149365.11311964CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KAVLKaival Brands Innovations Group Inc
$ 5.96
(338.24%)
70.99M
LRHCLa Rosa Holdings Corporation
$ 1.165
(90.61%)
40.6M
SVMHSRIVARU Holding Ltd
$ 0.227586
(49.24%)
276.03M
BRFHBarfresh Food Group Inc
$ 3.03
(38.36%)
247.31k
NNENano Nuclear Energy Inc
$ 9.37
(32.53%)
1.77M
NXLNexalin Technologies Inc
$ 0.89
(-35.52%)
3.93M
INABIN8bio Inc
$ 1.095
(-34.82%)
4.92M
QXOQXO Inc
$ 134.10
(-34.71%)
142.29k
GANXGain Therapeutics Inc
$ 1.24
(-34.39%)
3.09M
KYTXKyverna Therapeutics Inc
$ 9.52
(-34.07%)
4.31M
NVDANVIDIA Corporation
$ 131.88
(1.75%)
309.34M
SVMHSRIVARU Holding Ltd
$ 0.227586
(49.24%)
276.03M
KITTNauticus Robotics Inc
$ 0.1921
(19.69%)
165.83M
CRKNCrown Electrokinetics Corporation
$ 0.0582
(-21.35%)
136.77M
SQQQProShares UltraPro Short QQQ
$ 8.43
(-1.29%)
112.46M

HOWL Discussion

View Posts
Monksdream Monksdream 1 month ago
HOWL under $10
👍️0
Monksdream Monksdream 5 months ago
HOWL new 52 week high
👍️0
Pt3 Pt3 7 months ago
Yea your gap and trapped make me buy caud instead of this
👍️0
TheFinalCD TheFinalCD 7 months ago
HOWL todays algo patented Gap & Trap on Phase #1 news
👍️0
TheFinalCD TheFinalCD 7 months ago
Werewolf Therapeutics soars 52% premarket after presentsing preliminary monotherapy data from Phase 1/1b clinical trial establishing proof of mechanism for WTX-124$HOWL#AInvest #Ainvest_Wire #trade #source #wallstreet
View more: https://t.co/aTzfU7GqUS pic.twitter.com/rClSWzl2IS— AInvest Wire (@Ainvest_Wire) November 3, 2023
👍️0
TheFinalCD TheFinalCD 7 months ago
$howl flying https://finviz.com/quote.ashx?t=HOWL&ty=c&ta=1&p=d

https://dilutiontracker.com/app/search/HOWL
👍️0
tw0122 tw0122 8 months ago
$3 + otw Halloween is here give it a HOWL
👍️0
The Night Stalker The Night Stalker 12 months ago
https://stockcharts.com/h-sc/ui?s=howl&p=W&yr=0&mn=11&dy=25&id=p34307943936&a=1105106922&listNum=2
👍️0
The Night Stalker The Night Stalker 12 months ago
https://stockcharts.com/h-sc/ui?s=howl&p=W&yr=0&mn=11&dy=25&id=p34307943936&a=1105106922&listNum=2
👍️0
The Night Stalker The Night Stalker 12 months ago
dip
👍️0
The Night Stalker The Night Stalker 12 months ago
dip
👍️0
The Night Stalker The Night Stalker 12 months ago
watching
👍️0
The Night Stalker The Night Stalker 1 year ago
soon
👍️0
The Night Stalker The Night Stalker 1 year ago
insert dd
👍️0
The Night Stalker The Night Stalker 1 year ago
can be big
👍️0
The Night Stalker The Night Stalker 1 year ago
wow
👍️0
The Night Stalker The Night Stalker 1 year ago
wow
👍️0
The Night Stalker The Night Stalker 1 year ago
hold
👍️0
The Night Stalker The Night Stalker 1 year ago
slow
👍️0
The Night Stalker The Night Stalker 1 year ago
slow
👍️0
The Night Stalker The Night Stalker 1 year ago
agreed
👍️0
The Night Stalker The Night Stalker 1 year ago
like thiks
👍️0
The Night Stalker The Night Stalker 1 year ago
off radar
👍️0
The Night Stalker The Night Stalker 1 year ago
catchy name
👍️0
The Night Stalker The Night Stalker 1 year ago
catchy name
👍️0
surf1944 surf1944 1 year ago
https://stockcharts.com/h-sc/ui?s=howl&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/howl/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=SYSX&grid=1&height=210&studyheight=100

https://www.barchart.com/stocks/quotes/howl/opinion
👍️0
Mr. Zen Mr. Zen 1 year ago
Watch list addition, this has the potential to run, just waiting for all the pieces of the puzzle to come together.

“These promising preclinical data add to a growing body of evidence demonstrating the potential of WTX-330 to drive targeted anti-tumor immune responses selectively in the tumor microenvironment (TME),” said Cynthia Seidel-Dugan, Ph.D., Chief Scientific Officer of Werewolf Therapeutics. “This morning, in our Third Quarter 2022 release, we announced that the FDA has granted clearance of the investigational new drug (IND) application for WTX-330. We are excited to advance WTX-330 into the clinic and to continue developing a pipeline of novel proinflammatory cytokine therapies that have the potential to change the lives of cancer patients.”
👍️0
makinezmoney makinezmoney 1 year ago
$HOWL: Hey thanks....... now 3.20.

Only getting better right ??


Enjoy those profits.





GO $HOWL
👍️0
Makk1 Makk1 1 year ago
Good call here, looking very good
👍️0
makinezmoney makinezmoney 1 year ago
$HOWL: Looks like its turning...... now 2.25

Let see if volume pushes it up.


The setup is nice


GO $HOWL
👍️0
bobbo5 bobbo5 1 year ago
I agree and it looks like share price has been moving up this past week
👍️0
dia76ca dia76ca 2 years ago
Very interesting company. I like it's chances.
👍️0

Your Recent History

Delayed Upgrade Clock